| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 67.060 | 46.000 | -16.246 | 37.993 | 27.371 | 3.963 | 0 | 0 | 0 | - |
| Total Income - EUR | 68.072 | 46.000 | -16.242 | 37.993 | 27.371 | 3.980 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 58.870 | 44.068 | -3.595 | 36.772 | 32.186 | 7.537 | 2.498 | 1.000 | 940 | - |
| Gross Profit/Loss - EUR | 9.202 | 1.932 | -12.647 | 1.222 | -4.815 | -3.556 | -2.498 | -1.000 | -940 | - |
| Net Profit/Loss - EUR | 8.361 | 308 | -12.781 | 82 | -5.636 | -3.675 | -2.498 | -1.000 | -940 | - |
| Employees | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | - |
Check the financial reports for the company - Atrex Bio Med Pharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 59.672 | 68.481 | 49.709 | 36.653 | 43.502 | 39.823 | 37.667 | 36.860 | 35.821 | - |
| Inventories | 11.947 | 13.596 | 24.833 | 12.737 | 25.736 | 24.638 | 24.531 | 24.608 | 24.533 | - |
| Receivables | 11.802 | 31.042 | 13.180 | 11.019 | 7.831 | 7.089 | 7.096 | 7.206 | 7.256 | - |
| Cash | 35.923 | 23.843 | 11.696 | 12.898 | 9.936 | 8.096 | 6.040 | 5.046 | 4.032 | - |
| Shareholders Funds | 9.755 | 1.377 | -11.730 | -11.433 | -16.847 | -20.203 | -22.253 | -23.323 | -24.192 | - |
| Social Capital | 900 | 891 | 876 | 860 | 843 | 827 | 809 | 811 | 809 | - |
| Debts | 49.916 | 67.105 | 61.465 | 48.086 | 60.350 | 60.034 | 59.928 | 60.185 | 60.015 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Atrex Bio Med Pharm S.r.l.